Arteris (AIP) 27th Annual Needham Growth Conference summary

Financial performance and outlook

• Achieved $65 million in annual contract value plus royalties and delivered $1.1 million in free cash flow.

• Reported 11% year-over-year revenue growth and growth in ACV royalties and RPO, which is a leading indicator for future revenue.

• 2024 guidance targets $63–67 million in ACV plus royalties, free cash flow between -$900,000 and $1.1 million, and a GAAP operating loss of $4–5 million.

• Aims to be non-GAAP net income positive in the first half of 2026 and GAAP positive the following year.

• Targeting $100 million in revenue within three years, with expense growth at about half the revenue growth rate to achieve financial leverage.

Business model and market strategy

• Focuses on licensing IP, not manufacturing silicon, with a business model based on license fees and per-unit royalties, typically without royalty caps.

• Enhances each product line with two releases per year, funded by ongoing royalties.

• Maintains a defensive patent portfolio, filing 10–15 patents annually, with about 200 patent properties.

• Serves a broad customer base, including major players like Samsung and Intel, with 780 chips built using its IP and 230 active customers.

• Average project revenue is $560,000–$580,000, with royalties typically exceeding the initial license fee.

Technology and product development

• Invented network-on-chip (NoC) technology, offering lower power, area, and higher performance for semiconductor integration.

• Acquired Magillem in 2020 to expand into semiconductor integration automation.

• Delivers features for AI and automotive applications, such as tiling and mesh support for neural networks.

• Plans to deliver one new technology per year, working on two new products annually.

• Exploring chiplet solutions, particularly IO hubs, to address multi-die SoC needs.